The mRNA expression levels of the ITPRIPL1 gene were found to be elevated in CHOL, diffuse large B-cell lymphoma (DLBC), GBM, KIRC, acute myeloid leukemia (LAML), lower grade glioma (LGG), skin cutaneous melanoma (SKCM), STAD, uterine carcinosarcoma (UCS), while reduced in BRCA, PRAD and Testicular Germ Cell Tumors (TGCT). Here, ITPRIPL1 is linked to prostate adenocarcinoma.